Corbus Pharmaceuticals Holdings, Inc.
CRBP
$6.65
$0.528.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.56% | 613.01% | 454.63% | 302.08% | 171.56% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 143.67% | 48.24% | -45.49% | -33.95% | -9.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 48.44% | 48.05% | 48.05% | 48.05% |
| Total Current Assets | 12.87% | 549.69% | 415.57% | 287.50% | 165.34% |
|
|
|||||
| Total Current Assets | 12.87% | 549.69% | 415.57% | 287.50% | 165.34% |
| Net Property, Plant & Equipment | -40.32% | -37.61% | -34.16% | -31.03% | -28.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -44.20% | -43.27% | -44.15% | -41.66% |
| Total Assets | 11.28% | 451.35% | 352.47% | 247.59% | 143.48% |
|
|
|||||
| Total Accounts Payable | 95.41% | 50.55% | -38.75% | -23.49% | 57.35% |
| Total Accrued Expenses | -37.20% | -50.81% | -4.90% | 63.40% | 45.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -88.57% | -90.90% | -91.88% | 46.48% | 120.99% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -70.46% |
| Total Other Current Liabilities | -- | -- | -- | -- | -70.46% |
| Total Current Liabilities | -55.18% | -62.95% | -63.14% | 46.35% | 80.54% |
|
|
|||||
| Total Current Liabilities | -55.18% | -62.95% | -63.14% | 46.35% | 80.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -57.79% | -49.58% | -43.28% | -38.22% | -34.10% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -55.44% | -61.76% | -61.99% | -22.71% | -18.21% |
|
|
|||||
| Common Stock & APIC | 14.81% | 44.09% | 43.98% | 35.35% | 26.86% |
| Retained Earnings | -11.34% | -9.21% | -9.03% | -8.35% | -8.24% |
| Treasury Stock & Other | 93.00% | 3,600.00% | 2,687.50% | -1,530.25% | -379.56% |
| Total Common Equity | 31.08% | 2,162.68% | 48,291.64% | 1,218.65% | 489.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.08% | 2,162.68% | 48,291.64% | 1,218.65% | 489.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.08% | 2,162.68% | 48,291.64% | 1,218.65% | 489.13% |
|
|
|||||